Section Arrow
GKOS.NYSE
- Glaukos Corp
Quotes are at least 15-min delayed:2026/03/11 20:31 EDT
Regular Hours
Last
 102.86
-0.29 (-0.28%)
Day High 
104.14 
Prev. Close
103.15 
1-M High
123.16 
Volume 
508.16K 
Bid
92.98
Ask
105
Day Low
100.465 
Open
102.99 
1-M Low
99.84 
Market Cap 
5.99B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 114.57 
20-SMA 114.43 
50-SMA 115.45 
52-W High 130.23 
52-W Low 73.16 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-3.28/0.75
Enterprise Value
6.09B
Balance Sheet
Book Value Per Share
11.30
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
507.44M
Operating Revenue Per Share
5.23
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp69.63-0.33-0.47%36.06PE
ABTAbbott Laboratories110.25-0.3-0.27%29.72PE
MDTMedtronic plc88.97-0.92-1.02%25.14PE
PACBPacific Biosciences of California1.35-0.015-1.10%-- 
EWEdwards Lifesciences Corp85.09-0.69-0.80%47.39PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.